Skip to main content
SpringerLink
Log in

Impact on quality of life of adjuvant therapy for breast cancer

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Late toxicities of adjuvant chemotherapy and side effects of endocrine therapy may cause long-term quality-of-life impairments for some individuals who have been treated for breast cancer. Chemotherapy has been associated with durable effects on cognitive function and fatigue and with the induction of menopause. Endocrine therapies can increase menopausal and sexual symptoms and can contribute to weight gain. Overall, however, quality of life is good for the majority of breast cancer survivors who have received adjuvant systemic therapy. Behavioral interventions that target fatigue and sleep disturbance may further enhance quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Tchen N, Juffs HG, Downie FP, et al.:Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.J Clin Oncol 2003,21:4175–4183.

    Article  PubMed  Google Scholar 

  2. Mar Fan HG, Houede-Tchen N, Yi QL, et al.:Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1-and 2-year follow-up of a prospective controlled study.J Clin Oncol 2005,23:8025–8032.

    Article  Google Scholar 

  3. Donovan KA, Small BJ, Andrykowski MA, et al.:Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.Cancer 2005,104:2499–2507.

    Article  PubMed  Google Scholar 

  4. Jenkins V, Shilling V, Deutsch G, et al.:A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.Br J Cancer 2006,94:828–834.

    Article  PubMed  CAS  Google Scholar 

  5. Arndt V, Merx H, Stegmaier C, et al.:Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer.J Clin Oncol 2005,23:4945–4953.

    Article  PubMed  Google Scholar 

  6. Byer KL, Berger AM, Bakken SL, Cetak MA:Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life.Oncology Nursing Forum 2006,33:E18-E26.

    Article  Google Scholar 

  7. Schultz PN, Klein MJ, Beck ML, et al.:Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.J Clin Nursing 2005,14:204–211.

    Article  Google Scholar 

  8. Bower JE, Ganz PA, Desmond KA, et al.:Fatigue in long-term breast carcinoma survivors.Cancer 2006,106:751–758.

    Article  PubMed  Google Scholar 

  9. Ahles TA, Saykin AJ, Furstenberg CT, et al.:Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy.J Clin Oncol 2005,23:4399–4405.

    Article  PubMed  CAS  Google Scholar 

  10. Thewes B, Meiser B, Duric VM, et al.:What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? Lancet Oncol 2005,6:581–88.

    Article  PubMed  CAS  Google Scholar 

  11. Fallowfield LJ, Bliss JM, Porter LS, et al.:Quality of life in the Intergroup Exemestane Study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer.J Clin Oncol 2006,24:910–917.

    Article  PubMed  CAS  Google Scholar 

  12. Whelan TJ, Goss PE, Ingle JN, et al.:Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women.J Clin Oncol 2005,23:6931–6940.

    Article  PubMed  CAS  Google Scholar 

  13. Stanton AL, Bernaards CA, Ganz PA:The BCPT Symptom Scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer.J Natl Cancer Inst 2005,97:448–456.

    Article  PubMed  Google Scholar 

  14. Ohira T, Schmitz KH, Ahmed RL, Yee D:Effects of weight training on quality of life in recent breast cancer survivors: The Weight Training for Breast Cancer Survivors (WTBS) Study.Cancer 2006,106:2076–2083.

    Article  PubMed  Google Scholar 

  15. Pinto BM, Frierson GM, Rabin C, et al.:Home-based physical activity intervention for breast cancer patients.J Clin Oncol 2005,23:3577–3587.

    Article  PubMed  Google Scholar 

  16. Savard J, Simard S, Ivers H, Morin CM:Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, Part I: Sleep and psychological effects.J Clin Oncol 2005,23:6083–6096.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Taussig Cancer Center, Cleveland Clinic Foundation, 9500 Euclid Avenue, 44195, Cleveland, OH, USA

    Halle C. F. Moore MD

Authors
  1. Halle C. F. Moore MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Halle C. F. Moore MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moore, H.C.F. Impact on quality of life of adjuvant therapy for breast cancer. Curr Oncol Rep 9, 42–46 (2007). https://doi.org/10.1007/BF02951424

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02951424

Keywords

Search

Navigation